Patent · US Active

Heterocyclic NF-κB inhibitors

US7812041B2 · kind B2 · utility

2Cited by

1References

9Claims

0Family size

Assignee

4SC AG · DE

Inventors

Johann Leban · Planegg, DE
Harald Schmitt · Hersbruck, DE
Kristina Wolf · Kottgeisering, DE
Stefano Pegoraro · Planegg, DE
Andreas Wuzik · Untermeitingen, DE

Key dates

Filing date	Jul 29, 2005
Grant date	Oct 12, 2010
Priority date	—
Expiry date	Jan 14, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D495/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to compounds of the general formula (I) and salts and physiologically functional derivatives thereof,wherein

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.